期刊文献+

肝细胞肝癌化疗栓塞术后疗效与CD34的表达及意义

Efficacy after cells liver cancer chemoembolization and significance of CD34 expressions
下载PDF
导出
摘要 目的:回顾性分析肝细胞癌中CD34的表达与化疗栓塞术效果的关系。方法:对25例B超穿刺诊断为肝细胞癌,选择介入治疗的标本标记CD34,分析其免疫组化的表达与化疗栓塞术治疗后肿瘤碘油沉积情况及栓塞次数的关系。结果:肿物大小2~10cm,癌组织血窦样间质中,CD34均有表达,但阳性细胞的密度不一。经导管肝动脉化疗栓塞第一疗程常规连续治疗3次,25例中有4例2次治疗后复查CT显示碘油沉积良好,增强扫描未见肿瘤供血,未连续做第三次,3例连续治疗5次。随访4年,死亡22例,生存3例。结论:CD34的阳性表达与患者的生存无明显相关性,与治疗的次数及复发的时间有关。 Objective:To analysis the relation between the expressions of CD34 in liver cell cancer and the effect of chemoembolization. Methods :Twenty-five cases with liver cell cancer puncture diagnosed by B ultrasonic,mark the interventional therapy specimen with CD34,analysis the relation between the expressions of immunohistochemistry and the sedimentary situation of cancer lipiodol with the embolism times. Results :The size of tumor is 2-10 cm,there is CD34 expressions in cancer tissue sinusoids stroma,but the density of masculine cells is different. After first 3 suc- cessive conventional treatment with duct liver artery chemoembolization,4 cases out of 25 show good sedimentary sit- uation of lipiodol in CT re-inspection after two treatments ,there is no vascularity supply in strengthen scan,no three successive treatments, 3 cases with 5 treatments. After 4 years follow-up ,there are 22 deaths and 3 survivals. Conclu- sion..The survive of patients is not obviously related with the masculine expression of CD34,but related with the times of treatment and time of relapse.
机构地区 山西省肿瘤医院
出处 《临床医药实践》 2012年第12期931-932,共2页 Proceeding of Clinical Medicine
基金 山西省肿瘤医院院所资金资助项目
关键词 肝细胞癌 免疫组化 CD34介入治疗 liver cell cancer immunohistochemistry CD34 interventional therapy
  • 相关文献

参考文献7

  • 1Kobayash I N, Ishii M,Ueno Y,et al. Expression of Bc122 protein and vascular endothelial grow the fac- tor in hepatocelluar carcinomas treated by chemoem- bo lization[J]. Liver, 1999,19 (1) : 252-311.
  • 2Abraham J A,Mergia A,Whang L,et al. Nucleotide sequence of a bovine clone encoding the angiogenic protein, baesic fibroblast growth factor[J]. Science, 1986,233(4 763):545.
  • 3董辉,丛文铭.肝脏常见肿瘤的免疫病理学诊断新进展[J].诊断学理论与实践,2009,8(5):561-563. 被引量:5
  • 4董辉,丛文玲,朱忠政,王斌,冼志红,俞花.肝细胞癌与肝内胆管癌的免疫组化诊断[J].中华肿瘤杂志,2008,30(9):702-705. 被引量:12
  • 5Chebib I,Shabani,Rad M T,et al. Microvessel densi ty and clinicopathologie characteristics in hepatocel lular carcinoma with and without cirrhosis [J] Biomark Nsights, 2007 (2) : 59-68.
  • 6Kwee R M,Kwee T C. Imaging in local staging of gastric cancer : asystematic review[J]. J Clin Oncol, 2007,25(15) :2 107-2 116.
  • 7Blagosklonny M V. Antiangiogenic therapy and tu- mor progression[J]. Cancer Cell, 2004(5) :13-17.

二级参考文献19

  • 1丛文铭,张树辉,朱忠政,董辉.高分化肝细胞癌与肝良性结节性病变的病理鉴别诊断[J].临床与实验病理学杂志,2004,20(4):387-390. 被引量:6
  • 2Joanna W.Ho,Ronnie T.Poon,Chris K.Sun,Sheung-Tat Fan.Clinicopathological and prognostic implications of endoglin (CD105) expression in hepatocellular carcinoma and its adjacent non-tumorous liver[J].World Journal of Gastroenterology,2005,11(2):176-181. 被引量:16
  • 3Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002[J]. CA Cancer J Clin, 2005, 55(2): 74-108.
  • 4Hsu HC, Cheng W, Lai PL. Cloning and expression of a developmentally regulated transcript MXR7 in hepatocellular carcinoma: biological significance and temporospatial distribution[J}. Cancer Res, 1997, 57(22): 5179- 5184.
  • 5Wang HL, Anatelli F, Zhai Q J, et al. Glypican-3 as a useful diagnostic marker that distinguishes hepatocellular carcinoma from benign hepatocellular mass lesions [J]. Arch Pathol Lab Med, 2008, 132(11): 1723-1728.
  • 6Ibarrola C, Castellano VM, Colina F. Focal hyperplastic hepatocellular nodules in hepatic venous outflow obstruction: a clinicopathological study of four patients and 24 nodules[J]. Histopathology, 2004, 44(2): 172-179.
  • 7Sato Y, Harada K, Ikeda H, et al. Hepatic stellate cells are activated around central scars of focal nodular hyperplasia of the liver-a potential mechanism of central scar formation[J]. Hum Pathol, 2009, 40(2): 181-188.
  • 8Parham DM, Kelly DR, Donnelly WH, et al. Immunohistochemical and ultrastructural spectrum of hepatic sarcomas of childhood: evidence for a common histogenesis[J]. Mod Pathol, 1991, 4(5): 648-653.
  • 9Agaram NP, Baren A, Antonescu CR. Pediatric and adult hepatic embryonal sarcoma: a comparative uhrastructural study with morphologic correlations[J]. Uhrastruct Pathol, 2006, 30(6): 403-408.
  • 10Li YR, Akbari E, Tretiakova MS, et al. Primary hepatic malignant fibrous histiocytoma: clinicopathologic characteristics and prognostic value of ezrin expression[J]. Am J Surg Pathol, 2008, 32(8): 1144-1158.

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部